Gao et al. demonstrated that vanadate (V2O5) activates hypoxia-inducible factor 1 (HIF-1) signaling by upregulating HIF-1α expression, which subsequently increases VEGF production in DU145 human prostate carcinoma cells [51]. Here, VEGFA is linked to prostate carcinoma.